APA aipamena

Pollack, P. S., Chadwick, K. D., Smith, D. M., Billger, M., Hirshberg, B., Iqbal, N., & Boulton, D. W. (2017). Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin. Cardiovasc Diabetol.

Chicago Style aipamena

Pollack, Pia S., Kristina D. Chadwick, David M. Smith, Martin Billger, Boaz Hirshberg, Nayyar Iqbal, and David W. Boulton. "Nonclinical and Clinical Pharmacology Evidence for Cardiovascular Safety of Saxagliptin." Cardiovasc Diabetol 2017.

MLA aipamena

Pollack, Pia S., et al. "Nonclinical and Clinical Pharmacology Evidence for Cardiovascular Safety of Saxagliptin." Cardiovasc Diabetol 2017.